GSK plc (LON:GSK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,415.00
-20.00 (-1.39%)
Aug 14, 2025, 5:31 PM BST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| HIV | 7.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| HIV Growth | 8.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -30.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 3.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Meningitis | 1.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Meningitis Growth | 15.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Influenza | 408.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Influenza Growth | -19.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Established Vaccines | 3.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Established Vaccines Growth | 1.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Shingles | 3.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Shingles Growth | -5.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology | 1.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Growth | 56.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory, Immunology and Inflammation | 3.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory, Immunology and Inflammation Growth | 10.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory | 7.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Growth | -0.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other General Medicines | 3.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other General Medicines Growth | -6.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Commerical Operations | 31.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Commerical Operations Growth | 0.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Consumer Healthcare | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pandemic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pandemic Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pandemic Vaccines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pandemic Vaccines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -30.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 3.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | -3.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 318.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Operations Segment Profit | 15.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Operations Segment Profit Growth | -0.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research & Development Segment Profit | -5.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research & Development Segment Profit Growth | 2.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Healthcare Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -3.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 318.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| US Revenue | 16.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| US Revenue Growth | -0.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 6.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 6.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 8.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | -1.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|